PE20010238A1 - GENE DERIVED FROM LAWSONIA AND POLYPEPTIDES SodC, PEPTIDES AND RELATED PROTEINS AND THEIR USES - Google Patents
GENE DERIVED FROM LAWSONIA AND POLYPEPTIDES SodC, PEPTIDES AND RELATED PROTEINS AND THEIR USESInfo
- Publication number
- PE20010238A1 PE20010238A1 PE2000000445A PE0004452000A PE20010238A1 PE 20010238 A1 PE20010238 A1 PE 20010238A1 PE 2000000445 A PE2000000445 A PE 2000000445A PE 0004452000 A PE0004452000 A PE 0004452000A PE 20010238 A1 PE20010238 A1 PE 20010238A1
- Authority
- PE
- Peru
- Prior art keywords
- polypeptide
- sodc
- amino acid
- cell
- acid sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 4
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108010006464 Hemolysin Proteins Proteins 0.000 abstract 1
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000003228 hemolysin Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
SE REFIERE A UN POLIPEPTIDO INMUNOGENICO AISLADO O RECOMBINANTE QUE IMITA, REACCIONA CON UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO, CAPAZ DE LOGRAR LA PRODUCCION DE ANTICUERPOS, CONFERIR UNA RESPUESTA INMUNE PROTECTORA CONTRA LAWSONIA SPP SodC TAL COMO LAWSONIA INTRACELLULARIS CUANDO SE ADMINISTRA A UN AVE, PORCINO; ES SELECCIONADO DE: a)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE POR LO MENOS 70% DE IDENTIDAD DE SECUENCIA GENERAL CON LA SECUENCIA DE AMINOACIDO EN LA SEC ID NO:1 O LA SECUENCIA DE AMINOACIDOS CODIFICADA POR LA SECUENCIA DE NUCLEOTIDOS QUE CODIFICA EL SodC DE pALK13(ATCC 207196) ESENCIALMENTE LA SECUENCIA QUE CODIFICA EL SodC DE pALK14 (ATCC 207155); b)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDO QUE TIENE POR LO MENOS 50% DE IDENTIDAD GENERAL DE SECUENCIA CON LOS RESIDUOS 1 A 42 DE LA SEC ID NO:1; c)UN HOMOLOGO, ANALOGO, DERIVADO DE QUE IMITA UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO DE LAWSONIA SPP SodC. SE REFIERE TAMBIEN A UNA VACUNA QUE COMPRENDE ADEMAS UN SEGUNDO COMPONENTE INMUNOGENICO QUE COMPRENDE UN PEPTIDO, POLIPEPTIDO, PROTEINA ANTIGENICA DE L. INTRACELLULARIS TAL COMO OmpH, FlgE, HEMOLISINA, AUTOLISINA; UN VECTOR PARA VACUNA, MOLECULA AISLADA DE ACIDO NUCLEICO, PLASMIDO pALK14REFERS TO AN ISOLATED OR RECOMBINANT IMMUNOGENIC POLYPEPTIDE THAT IMMITATES, REACTS WITH A CELL B OR T CELL EPITOPE OF A POLYPEPTIDE, CAPABLE OF ACHIEVING THE PRODUCTION OF ANTIBODIES, CONFERRING A PROTECTIVE IMMUNE RESPONSE TO THE SPACELLA SPACIN CULA SODWSON ADDWSON SUCH AS THE PROTECTIVE TACINWO SADWSON. A BIRD, PORCINE; IT IS SELECTED FROM: a) A PEPTIDE, OLIGOPEPTIDE, POLYPEPTIDE INCLUDING AN AMINO ACID SEQUENCE THAT HAS AT LEAST 70% GENERAL SEQUENCE IDENTITY WITH THE AMINO ACID SEQUENCE IN SEQ ID NO: 1 OR THE AMINO ACID SEQUENCE CODED BY THE NUCLEOTIDE SEQUENCE ENCODED BY pALK13 SodC (ATCC 207196) ESSENTIALLY THE SEQUENCE ENCODED BY pALK14 SodC (ATCC 207155); b) A PEPTIDE, OLIGOPEPTIDE, POLYPEPTIDE INCLUDING AN AMINO ACID SEQUENCE THAT HAS AT LEAST 50% GENERAL SEQUENCE IDENTITY WITH RESIDUES 1 TO 42 OF SEQ ID NO: 1; c) A HOMOLOGICAL, ANALOGUE, DERIVED FROM THAT IMITATING AN EPITOPE OF CELL B OR CELL T OF A POLYPEPTIDE OF LAWSONIA SPP SodC. IT ALSO REFERS TO A VACCINE THAT ALSO INCLUDES A SECOND IMMUNOGENIC COMPONENT THAT INCLUDES A PEPTIDE, POLYPEPTIDE, ANTIGENIC PROTEIN OF L. INTRACELLULARIS SUCH AS OmpH, FlgE, HEMOLYSIN, AUTOLYSIN; A VECTOR FOR VACCINE, ISOLATED NUCLEIC ACID MOLECULE, PLASMID pALK14
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13398999P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010238A1 true PE20010238A1 (en) | 2001-03-03 |
Family
ID=22461256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000445A PE20010238A1 (en) | 1999-05-13 | 2000-05-12 | GENE DERIVED FROM LAWSONIA AND POLYPEPTIDES SodC, PEPTIDES AND RELATED PROTEINS AND THEIR USES |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1177212A4 (en) |
| JP (1) | JP2003501013A (en) |
| AR (1) | AR023975A1 (en) |
| AU (1) | AU4385800A (en) |
| BR (1) | BR0011292A (en) |
| CA (1) | CA2372095A1 (en) |
| MX (1) | MXPA01011670A (en) |
| NZ (1) | NZ515332A (en) |
| PE (1) | PE20010238A1 (en) |
| WO (1) | WO2000069903A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| ES2360225T3 (en) | 2000-12-20 | 2011-06-02 | Intervet International Bv | VACCINE AGAINST LAWSONIA INTRACELLULARIS. |
| DE602004024423D1 (en) | 2003-09-12 | 2010-01-14 | Intervet Int Bv | VACCINE WITH LAWSONIA INTRACELLULARIS SUB-UNIT |
| EP1709067B1 (en) | 2004-01-22 | 2010-06-09 | Intervet International BV | Lawsonia intracellularis subunit vaccines |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| CN111830257B (en) * | 2020-07-17 | 2023-10-24 | 南京农业大学 | An IPMA antigen detection method for Lawsonia intracellularis derived from pigs and its application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| CA2236574A1 (en) * | 1995-11-30 | 1997-06-05 | Daratech Pty. Ltd. | Therapeutic and diagnostic compositions |
-
2000
- 2000-05-11 BR BR0011292-5A patent/BR0011292A/en not_active IP Right Cessation
- 2000-05-11 JP JP2000618319A patent/JP2003501013A/en active Pending
- 2000-05-11 WO PCT/AU2000/000436 patent/WO2000069903A1/en not_active Ceased
- 2000-05-11 MX MXPA01011670A patent/MXPA01011670A/en unknown
- 2000-05-11 NZ NZ515332A patent/NZ515332A/en unknown
- 2000-05-11 EP EP00924975A patent/EP1177212A4/en not_active Withdrawn
- 2000-05-11 AU AU43858/00A patent/AU4385800A/en not_active Abandoned
- 2000-05-11 CA CA002372095A patent/CA2372095A1/en not_active Abandoned
- 2000-05-12 PE PE2000000445A patent/PE20010238A1/en not_active Application Discontinuation
- 2000-05-12 AR ARP000102294A patent/AR023975A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1177212A1 (en) | 2002-02-06 |
| AR023975A1 (en) | 2002-09-04 |
| BR0011292A (en) | 2002-02-26 |
| MXPA01011670A (en) | 2003-10-14 |
| AU4385800A (en) | 2000-12-05 |
| WO2000069903A1 (en) | 2000-11-23 |
| CA2372095A1 (en) | 2000-11-23 |
| EP1177212A4 (en) | 2002-08-28 |
| NZ515332A (en) | 2004-01-30 |
| JP2003501013A (en) | 2003-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800973A1 (en) | POLYPEPTID BELKA-106 OF THE EXTERNAL MORAXELLA CATARRHALIS MEMBRANE, SEQUENCE OF THE GENE AND THEIR APPLICATION | |
| IL133056A (en) | Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same | |
| CA2230885A1 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
| DE60332645D1 (en) | II-KEY / ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINE | |
| BRPI0412799A (en) | immunogen, composition, nucleic acid, recombinant cell, methods for preparing a polypeptide, for inducing a protective immune response in a patient and for inducing an anamnesic response in a patient, and optimized yeast nucleic acid sequence | |
| NZ331829A (en) | Clostridium perfringens vaccines | |
| PE20231212A1 (en) | PROTEOLITICALLY STABLE VARIANT POLYPEPTIDES OF U1-AGATOXIN-TA1B FOR PEST CONTROL | |
| HU9203449D0 (en) | Varied cd44 surfacial proteins, dna sequences coding them, antibodies acting against these proteins as well as application of all these things in diagnostics and therapy | |
| SE9402089D0 (en) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| PE20010238A1 (en) | GENE DERIVED FROM LAWSONIA AND POLYPEPTIDES SodC, PEPTIDES AND RELATED PROTEINS AND THEIR USES | |
| PE20020857A1 (en) | FUSION PROTEINS WHOSE PART OF THE N-TERMINAL IS A DERIVATIVE OF HIRUDIN FOR THE PRODUCTION OF RECOMBINANT PROTEINS THROUGH SECRESSION BY YEAST | |
| KR880000589A (en) | Flavivirus antigen | |
| WO2002008716A3 (en) | Method for screening peptides for use in immunotherapy | |
| PE20010237A1 (en) | GENE DERIVED FROM LAWSONIA AND OmpH POLYPEPTIDES, PEPTIDES AND RELATED PROTEINS AND THEIR USES | |
| WO2003090667A3 (en) | Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus | |
| PE20010239A1 (en) | GENE DERIVED FROM LAWSONIA AND RELATED POLYPEPTIDES, PEPTIDES AND PROTEINS OF HEMOLYSIN AND THEIR USES | |
| WO2006116763A3 (en) | Lawsonia intracellularis immunological proteins | |
| DE69935599D1 (en) | MODIFIED HCV PEPTIDE VACCINES | |
| PE20010316A1 (en) | GENE DERIVED FROM LAWSONIA AND RELATED POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES | |
| CA2158024A1 (en) | A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof | |
| BR0209854A (en) | Recombinant Nucleic Acid Molecule, expression cassette, vector, polypeptide, vaccine composition, particle acceleration device, and method for generating a cellular immune response in an individual | |
| ATE312923T1 (en) | MORAXELLA CATARRHALIS BASB034 POLYPEPTIDES AND USES THEREOF | |
| WO2004056316A8 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| AR004191A1 (en) | POLYPEPTIDES TO INDUCE PROTECTIVE IMMUNITY AGAINST TUBERCULOSIS, DNA MOLECULES THAT CODES THEM, A VECTOR OF EXPRESSION, A HOST CELL, A VACCINE, A FUSION PROTEIN, A METHOD OF DETECTING TUBERCULOSIS | |
| TH61176A (en) | Nucleic acids that provide polypeptide ciphers associated with the passage into PRRS virus cells. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |